iShares Biotechnology ETF Rating $186.41 -3.55 (-1.87%) As of 07/31/2026 04:00 PM Eastern Add Compare Share Share Ratings Stock AnalysisChartDividendHeadlinesHoldingsOptions ChainOwnershipRatingsSEC FilingsShort InterestTrendsBuy This Stock iShares Biotechnology ETF Aggregate Rating and Price Target (2026)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.IBB Aggregate RatingModerate Buy 2.71Holdings in IBB have an aggregate rating of Moderate Buy based on 525 analyst ratings issued in the past year covering 25 companies (65.7% of the portfolio).IBB Aggregate Price Target$186.41High Prediction$186.41Average Prediction$186.41Low Prediction$186.41Holdings in IBB have an aggregate price target of $186.41 and a range of $186.41 to $186.41 covering 25 companies (65.7% of the portfolio).IBB Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy2 Buy rating(s)Moderate Buy17 Moderate Buy rating(s)Hold5 Hold rating(s)Reduce1 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by iShares Biotechnology ETF Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 25 IBB Holdings ExportWeight In ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings8.25%AMGNAmgen$385.16-0.6%3.9381 of 5 stars2.43$357.00 -7.3%30Trending NewsUpcoming EarningsDividend AnnouncementAnalyst Forecast7.88%VRTXVertex Pharmaceuticals$477.10-1.0%4.4876 of 5 stars2.88$559.61 17.3%25Positive NewsUpcoming EarningsAnalyst Revision7.10%GILDGilead Sciences$130.21-0.8%4.9042 of 5 stars2.86$157.93 21.3%29Trending NewsUpcoming EarningsAnalyst ForecastAnalyst Revision5.24%REGNRegeneron Pharmaceuticals$762.63+3.3%3.8892 of 5 stars2.70$794.83 4.2%27Trending NewsEarnings ReportDividend AnnouncementAnalyst Forecast3.77%ARGXargenex$853.82-2.1%4.4399 of 5 stars2.92$1,056.89 23.8%24Positive NewsAnalyst ForecastAnalyst Revision2.86%ALNYAlnylam Pharmaceuticals$205.52+0.0%4.8018 of 5 stars2.83$410.72 99.8%24Trending NewsAnalyst ForecastHigh Trading Volume2.85%RVMDRevolution Medicines$187.53-2.4%1.82 of 5 stars2.95$144.67 -22.9%22Positive NewsUpcoming Earnings2.83%NTRANatera$267.76-0.7%2.7046 of 5 stars2.82$267.83 0.0%22Upcoming EarningsInsider Trade2.34%BIIBBiogen$202.95-2.4%3.8025 of 5 stars2.56$223.36 10.1%32Trending NewsEarnings ReportAnalyst Upgrade2.32%ILMNIllumina$205.10+0.0%2.6682 of 5 stars2.39$175.47 -14.4%18Trending NewsEarnings ReportAnalyst ForecastHigh Trading Volume2.05%ONCBeOne Medicines$316.01-1.9%4.715 of 5 stars2.88$394.00 24.7%16Upcoming EarningsInsider Trade1.84%INCYIncyte$119.52-2.8%2.8681 of 5 stars2.36$117.74 -1.5%22Earnings ReportAnalyst Forecast1.82%INSMInsmed$98.60-2.8%3.67 of 5 stars3.00$209.35 112.3%26Positive NewsUpcoming EarningsAnalyst Forecast1.72%UTHRUnited Therapeutics$517.71-1.5%4.7172 of 5 stars2.85$648.33 25.2%13Positive NewsUpcoming EarningsInsider Trade1.55%MRNAModerna$54.82-5.4%1.5815 of 5 stars1.82$40.00 -27.0%17Trending NewsEarnings ReportOptions Volume1.43%ROIVRoivant Sciences$33.91-1.8%1.6223 of 5 stars2.75$33.59 -0.9%12Positive NewsUpcoming EarningsAnalyst ForecastInsider Trade1.37%NBIXNeurocrine Biosciences$166.80-10.1%4.815 of 5 stars2.96$199.64 19.7%24Trending NewsAnalyst UpgradeInsider TradeHigh Trading Volume1.24%ASNDAscendis Pharma A/S$243.91-2.9%4.8236 of 5 stars3.05$296.72 21.7%19News CoveragePositive NewsUpcoming Earnings1.19%GMABGenmab A/S$28.87+0.8%4.5626 of 5 stars2.85$39.28 36.1%13Positive NewsUpcoming EarningsAnalyst Upgrade1.12%BBIOBridgeBio Pharma$80.09-2.5%3.3388 of 5 stars2.83$95.21 18.9%23Positive NewsUpcoming Earnings1.09%MEDPMedpace$577.11-0.2%2.8648 of 5 stars2.15$584.18 1.2%13Positive NewsInsider Trade1.07%EXELExelixis$53.03-5.3%2.824 of 5 stars2.37$49.29 -7.1%19Positive NewsUpcoming Earnings0.93%MDGLMadrigal Pharmaceuticals$467.32-5.2%3.9974 of 5 stars2.72$688.20 47.3%18Trending NewsEarnings ReportAnalyst ForecastShort Interest DecreaseHigh Trading Volume0.90%ARWRArrowhead Pharmaceuticals$84.65-3.1%2.3074 of 5 stars2.62$96.92 14.5%13Upcoming EarningsAnalyst ForecastAnalyst Revision0.89%BMRNBioMarin Pharmaceutical$60.02-0.9%4.5576 of 5 stars2.71$88.26 47.1%24Positive NewsUpcoming Earnings This page (NASDAQ:IBB) was last updated on 8/1/2026 by MarketBeat.com Staff. From Our PartnersALERT: Drop these 5 stocks before the market opens tomorrow!The Wall Street Journal is already raising the alarm about a potential market crash, and Weiss Ratings researc...Weiss Ratings | SponsoredLouis Navellier: My #1 AI stock for 2026 (name & ticker inside)Louis Navellier's Stock Grader system helped him flag Nvidia before its 82,000% run and has identified the top...InvestorPlace | SponsoredTrump Takes Emergency Action - Plus Elon Musk's New VentureElon Musk has quietly launched a new venture - one that has nothing to do with rockets, EVs, or Neuralink. Tru...Altimetry | SponsoredReady to give options a try? Your first trade (Ticker included) -INSIDETired of trying tactic after tactic when it comes to options trades... only to be met with market noise and st...Base Camp Trading | SponsoredTrump's gold order: the announcement they won't put on the front pageOn August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no deb...Reagan Gold Group | SponsoredMy top 3 AI picks for the next decadeAlexander Green bought Apple in 1996, recommended Nvidia at a split-adjusted 66 cents in 2004, and picked up A...The Oxford Club | SponsoredBofA: Digital Dollar Coming 2025-2030Bank of America just revealed your expiration date. In their Bloomberg interview, they didn't just predict the...Decentralized Masters | SponsoredElon's new "super startup"Adam O'Dell - the analyst who recommended Palantir before it became the top S&P 500 performer - has identified...Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding iShares Biotechnology ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share iShares Biotechnology ETF With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
